Research programme: serotonin 1 receptor antagonists - GlaxoSmithKline
Alternative Names: SB-616234A; SB-649915Latest Information Update: 18 Apr 2011
At a glance
- Originator GlaxoSmithKline
- Class Indoles; Oxazines; Piperazines
- Mechanism of Action 5-HT1 serotonin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Anxiety disorders; Major depressive disorder
Most Recent Events
- 19 Jun 2008 Preclinical development is ongoing
- 02 Oct 2003 Preclinical trials in Anxiety disorders in United Kingdom (unspecified route)
- 02 Oct 2003 Preclinical trials in Depression in United Kingdom (unspecified route)